News

Trevigen Recieves $202,050 Phase I SBIR Grant to Develop a Platform for Functional DNA Repair Measurements

press release


Trevigen Awarded $1,500,000 Phase II SBIR Grant to Bring to Market the CometChip™: a Multi-Purpose High- Throughput Platform for DNA Damage and Repair Quantitation

press release


Trevigen Releases the Only Commercially Available Pharmacodynamic Assay to Monitor DNA Double Strand Breaks in Cancer Patients

press release


Trevigen Receives a NIH SBIR Contract to Develop a Tumor Aligned 3D Coculture System

press release